Nektar Therapeutics (NKTR)
82.75
-0.47
(-0.56%)
USD |
NASDAQ |
Apr 16, 13:10
Nektar Therapeutics Market Cap : 1.432B for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 94.73B |
| Soleno Therapeutics, Inc. | 2.715B |
| Eli Lilly & Co. | 805.91B |
| Regeneron Pharmaceuticals, Inc. | 79.20B |
| Esperion Therapeutics, Inc. | 534.17M |
Market Cap Related Metrics
| PS Ratio | 98.98 |
| PEG Ratio | -0.0019 |
| Price to Book Value | 15.94 |
| Price | 82.75 |
| Earnings Yield | -8.27% |
| PEGY Ratio | -0.0019 |